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Many Gram-negative pathogens use a type IV secretion system (T4SS) to deliver effector proteins into eukaryotic host
cells. The fidelity of protein translocation depends on the efficient recognition of effector proteins by the T4SS.
Legionella pneumophila delivers a large number of effector proteins into eukaryotic cells using the Dot/Icm T4SS. How
the Dot/Icm system is able to recognize and control the delivery of effectors is poorly understood. Recent studies
suggest that the IcmS and IcmW proteins interact to form a stable complex that facilitates translocation of effector
proteins by the Dot/Icm system by an unknown mechanism. Here we demonstrate that the IcmSW complex is necessary
for the productive translocation of multiple Dot/Icm effector proteins. Effector proteins that were able to bind IcmSW
in vitro required icmS and icmW for efficient translocation into eukaryotic cells during L. pneumophila infection. We
identified regions in the effector protein SidG involved in icmSW-dependent translocation. Although the full-length
SidG protein was translocated by an icmSW-dependent mechanism, deletion of amino terminal regions in the SidG
protein resulted in icmSW-independent translocation, indicating that the IcmSW complex is not contributing directly to
recognition of effector proteins by the Dot/Icm system. Biochemical and genetic studies showed that the IcmSW
complex interacts with a central region of the SidG protein. The IcmSW interaction resulted in a conformational change
in the SidG protein as determined by differences in protease sensitivity in vitro. These data suggest that IcmSW
binding to effectors could enhance effector protein delivery by mediating a conformational change that facilitates
T4SS recognition of a translocation domain located in the carboxyl region of the effector protein.
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Introduction
Many Gram-negative bacteria utilize a type IV secretion
system (T4SS) to deliver proteins and DNA into a recipient
cell [1]. The Legionella pneumophila Dot/Icm T4SS is an essential
virulence determinant that translocates effector proteins into
eukaryotic cells [2–4]. Effector proteins translocated by the
Dot/Icm system function to delay endocytic maturation of the
vacuole in which the bacterium resides, as well as promote
remodeling of the L. pneumophila–containing vacuole into an
organelle that resembles the endoplasmic reticulum (ER) [5–
10]. L. pneumophila replication occurs in the ER-derived
vacuole created by these Dot/Icm-dependent processes
[2,3,11]. Currently, over 50 effector proteins have been shown
to be translocated into eukaryotic cells by the Dot/Icm T4SS,
and recent predictions suggest that there could be as many as
150 effectors [12–26].
Several studies have demonstrated that C-terminal regions
of effector proteins are required for translocation into
recipient cells by the T4SS [13,27–34]. Analysis of Dot/Icm
effectors has not revealed signiﬁcant primary sequence
homology in the C-terminal regions of effector proteins.
However, C-terminal translocation domains are thought to
have shared biophysical properties critical for translocation
by the T4SS. Currently, the only crystal structure of a type IV
effector available is for the RalF protein of L. pneumophila [35].
RalF has a C-terminal domain of 20 amino acids (aa) that is
necessary and sufﬁcient for Dot/Icm-mediated protein trans-
location into host cells [14,32]. The RalF crystal structure
revealed that this C-terminal domain is largely disordered
and separated from the protein’s globular domains by a long
alpha helix [35]. Thus, for RalF there is evidence that a
disordered C-terminal translocation domain is available for
interaction with T4SS components and that the availability of
this C-terminal domain is sufﬁcient for substrate recognition
by the Dot/Icm system.
In contrast to RalF, recent studies have identiﬁed effectors
that require the IcmS and IcmW proteins for efﬁcient
translocation [21,25,36]. IcmS and IcmW are small (12 and
18 kDa, respectively) acidic (pI ;4) cytoplasmic proteins that
have physical properties consistent with chaperone molecules
found in many type III secretion systems [37]. L. pneumophila
DicmS or DicmW strains retain the ability to replicate in
macrophage-like cell lines, induce contact-dependent for-
mation of pores in macrophage membranes, and secrete the
DotA protein into culture supernatant [11,36,38]. All of these
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suggesting that IcmS and IcmW are not essential components
of the Dot/Icm secretion machinery.
In previous studies, the IcmS and IcmW proteins were
found to interact and form a complex in the L. pneumophila
cytoplasm [21,39,40]. Additionally, the IcmS protein has been
shown to stabilize IcmW in the bacterial cell, indicating that
the IcmS–IcmW interaction is biologically signiﬁcant. There
is both genetic and biochemical evidence that IcmS and
IcmW associate with a subset of Dot/Icm effectors [21,25], and
that translocation of effectors that associate with the IcmSW
complex is reduced in DicmS and DicmW strains [21].
Interestingly, RalF is currently the only effector translocated
into host cells independent of the IcmS and IcmW proteins,
and it has been shown that IcmSW does not bind to RalF in
vitro [21]. These data indicate that IcmS and IcmW play an
important role in the translocation of some, but not all of the
effectors of the Dot/Icm T4SS, suggesting that the IcmSW
complex might be critical for the type IV recognition of a
particular class of effector proteins. Here, we set out to
further explore this possibility by investigating how the
IcmSW complex contributes to the translocation of type IV
substrates.
Results
The IcmSW Complex Is Necessary for the Translocation of
Multiple Effector Proteins
Previous studies indicated that Dot/Icm effector proteins
can be separated into different classes based on their
requirement for icmS and icmW, suggesting that the IcmSW
complex may target a particular set of substrates [21]. The sid
(substrate of icm-dot transporter) genes encode a diverse
group of proteins transported by the Dot/Icm system, some of
which were shown to be translocated by a mechanism
involving the IcmSW complex [13,21,25]. These effectors do
not demonstrate primary sequence homology. Several of the
Sid proteins have regions containing predicted coiled-coil
regions and hydrophobic segments that are predicted to
represent membrane-spanning regions (Figure S1). To deﬁne
the repertoire of Sid proteins utilizing IcmSW for trans-
location by the Dot/Icm system, reporter proteins were
constructed that consist of the catalytic domain of the
calmodulin-dependent adenylate cyclase (Cya) from Bordetella
pertussis fused to the amino terminus of each Sid protein. The
production of cyclic adenosine-monophosphate (cAMP)
resulting from the translocation of a Cya-Sid hybrid into
mammalian cells was used to measure productive trans-
location of each effector [32,41]. These data show that all of
the Cya-Sid fusion proteins were translocated by L. pneumo-
phila into host cells by a Dot/Icm-dependent mechanism
(Figure S1). When the Cya-Sid proteins were expressed in
either DicmS or DicmW strains, a signiﬁcant decrease in
translocation was observed for all hybrids with the exception
of Cya-SidF, which was translocated at nearly wild-type levels
by either the DicmS or DicmW strain (Figure 1A). The icmS or
icmW independence observed for SidF translocation was
similar to that shown previously for RalF [21]. The defect in
Figure 1. The IcmSW Complex Is Necessary for the Translocation of Multiple Effector Proteins
(A) CHO FccRII cells were left uninfected (hatch), or infected with wild-type (black), DicmS (light grey), or DicmW (dark grey) L. pneumophila strains
expressing the indicated Cya hybrid proteins. After 1 h of infection, tissue culture cells were lysed and cAMP was extracted from the sample. Total cAMP
production induced by translocation of the hybrid was quantified using an enzyme-immunoassay system, indicated as fmol. Results represent average
values 6 SD of experiments performed in triplicate.
(B) Immunoblots of whole-cell bacterial extracts expressing indicated Cya hybrid proteins from wild-type (WT), DdotA (A), DicmS (S), and DicmW (W)
probed with monoclonal antibody specific to the M45 epitope.
doi:10.1371/journal.ppat.0030188.g001
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Author Summary
Intracellular pathogens often manipulate the activities of the
eukaryotic host cell in which they reside by using a specialized
transport apparatus known as a type IV secretion system to deliver
proteins that directly manipulate host cell processes. How proteins
to be delivered into eukaryotic cells are recognized by a type IV
section system is not well understood. For Legionella pneumophila,
the bacterium that causes a severe pneumonia known as Legion-
naires disease, a type IV system called Dot/Icm is used to deliver an
estimated 150 different proteins into host cells during infection. In
this study, we demonstrate that a complex consisting of the
proteins IcmS and IcmW bind many of the substrate proteins
transported into eukaryotic host cells by the Dot/Icm system.
Binding of the IcmSW complex to Dot/Icm substrate proteins
enhanced the efficiency by which the substrate proteins were
transported into cells by a process that involved altering the
conformation of the substrate protein. Thus, this work defines a step
that is important for the type IV secretion process and provides new
molecular details on substrate protein recognition by type IV
secretion systems.translocation of Sid proteins by dot and icm mutants was not
due to a loss of stability, as steady-state protein levels of the
hybrids were similar in wild-type, DdotA, DicmS,o rDicmW
strains (Figure 1B).
Because the IcmS and IcmW proteins might retain partial
activity when they are not in a complex with each other,
translocation of the Sid proteins was analyzed in an L.
pneumophila strain lacking both icmS and icmW. The trans-
location of most Cya fusion proteins was reduced in the
DicmS, DicmW double mutant compared to either single
mutant. An additive translocation defect was observed for
Cya-SidA when data for wild-type L. pneumophila was
compared to the single mutants DicmS or DicmW, and the
DicmS, DicmW double mutant (Figure 2A). Translocation of
SidA, SidB, SidC, SidD, SidE, SidG, and SidH decreased
roughly 10-fold in the DicmS, DicmW double mutant compared
with the single DicmS mutant (Figure 2B). Although SidF
translocation was largely independent of icmS or icmW in the
single mutants, translocation of SidF was reduced by nearly
100-fold in the DicmS, DicmW double mutant (Figure 2B).
Additionally, IcmSW was isolated in a complex with SidF
when the three proteins were co-expressed in Escherichia coli
(unpublished data). Translocation of RalF was not severely
attenuated in the DicmS, DicmW double mutant, providing
further evidence that RalF is an IcmSW-independent effector
(Figure 2B). Equal translocation of SidF by wild-type L.
pneumophila in cytochalasin D–treated cells indicates that that
delivery of this effector by the Dot/Icm system does not
require bacterial internalization (Figure 2B). There was a
similar defect in Sid protein translocation by the DicmS,
DicmW double mutant observed when bacterial uptake was
blocked using cytochalasin D (Figure 2B). This result
indicated that the defect in effector translocation was not
due to differences in the vacuoles that the DicmS, DicmW
double mutant occupied compared with wild-type L. pneumo-
phila. Fusion protein levels were similar in wild-type L.
pneumophila and the DicmS, DicmW double mutant, indicating
that the translocation defect observed for the double mutant
is not due to a difference in steady-state protein levels (Figure
2C). No defect in internalization of the DicmS, DicmW double
mutant was observed when compared to wild-type L. pneumo-
phila, indicating that translocation differences were not due
to differences in uptake of the two strains (Figure 2D).
The translocation efﬁciency of each Cya-Sid fusion protein
by the single DicmS or DicmW mutants or the DicmS, DicmW
double mutant was calculated as the percent of cAMP relative
to the wild-type control strain producing the same fusion
protein. The average translocation defect for each strain was
calculated using these efﬁciency values (Figure 2E). These
data show a signiﬁcant decrease in Sid translocation in both
the DicmW and DicmS single mutants. Although the defect
observed for the icmS mutant was larger than the defect for
the DicmW mutant, this difference was not statistically
signiﬁcant. A signiﬁcant reduction in translocation efﬁciency
was observed in the DicmS, DicmW double mutant when
compared with the single mutants. These data demonstrate
that a functional IcmSW complex is critical for the efﬁcient
translocation of multiple effector proteins and suggests that
IcmS and IcmW may retain partial activity when they are not
in a complex with the other protein.
SidG Contains a C-Terminal Translocation Signal
The SidG protein demonstrated a strict requirement for
icmS and/or icmW for efﬁcient translocation. SidG contains a
predicted coiled-coil region, as well as two distinct hydro-
phobic segments that may represent membrane-spanning
regions (Figure 3A). Deletion analysis was used to map the
translocation signal in SidG. Deletion of 35 aa from the SidG
Figure 2. Translocation Defects Observed for the L. pneumophila DicmS,
DicmW Double Mutant
(A) CHO FccRII cells were infected with wild-type (black), DicmW (dark
grey), DicmS (light grey), or DicmS, DicmW (white) strains expressing Cya-
SidA. Total cAMP production was determined as in Figure 1.
(B) CHO FccRII cells were infected with wild-type (black) or DicmS, DicmW
(grey) strains expressing the indicated Cya hybrid proteins for 1 h. Wild-
type (hatch) or DicmS, DicmW (white) indicate samples that were
conditioned with cytochalasin D prior to infection. Total cAMP
production induced by translocation of the hybrid was determined as
in (Figure 1).
(C) Immunoblots of whole-cell bacterial extracts expressing indicated Cya
hybrid proteins from wild-type (WT) or DicmS, DicmW (D) probed with
monoclonal antibody specific to the M45 epitope. Immunoblots for
chloramphenicol acetyltransferase (Cat) are included as a load control.
(D) CHO FccRII cells were infected with wild-type (black) or DicmS,
DicmW (grey) L. pneumophila strains expressing Cya-SidG. Bacteria (3 3
10
6; MOI¼30) were added to each well (input line) and subjected to the
conditions indicated.þ/ Cyto D indicates the addition of cytochalasin D
(10 lM) 30 min prior to and during infection. þ/  Gent indicates the
addition of gentamycin (10 lM) 15 min post-infection. After 1 h of
infection, tissue culture cells were washed and osmotically lysed. Lysates
were serially diluted, plated, and incubated to determine total colony-
forming units (CFU) from each condition. Bars represent average values
6 SD of experiments performed in triplicate.
(E) Graphical representation of the average translocation efficiency of the
icmSW-dependent substrates SidA, SidB, SidC, SidD, SidE, SidG, and SidH.
Translocation of each construct in wild-type is considered 100%. The
average % defect is plotted for the DicmS, DicmW, and DicmS, DicmW
strains 6 SD of translocation assays performed in triplicate. p-Values
from Student’s t-test are indicated as comparisons between strains.
doi:10.1371/journal.ppat.0030188.g002
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IcmSW Interactions with Dot/Icm EffectorsC-terminus abrogated translocation of the protein into host
cells, demonstrating that this C-terminal region is necessary
for Dot/Icm-dependent translocation (Figure 3B). Consistent
with this region encoding a translocation signal, a Cya hybrid
containing only the C-terminal 20 aa of SidG(946–965) was
sufﬁcient to promote Dot/Icm-mediated protein transloca-
tion (Figure 3C). Overall, these data deﬁne a C-terminal
region in SidG that is necessary and sufﬁcient for Dot/Icm-
mediated translocation.
A Central Region in SidG Confers the icmSW-Dependent
Translocation Phenotype
To investigate whether the IcmSW complex is important
for recognition of the C-terminal translocation domain of an
icmSW-dependent effector, we measured translocation of a
Cya hybrid containing a C-terminal 30-aa region of SidG
containing the translocation signal. These data show that
efﬁcient translocation of the Cya-SidG(936–965) protein did not
require the IcmS and IcmW proteins (Figure 4A). Thus, the
IcmSW complex does not contribute directly to the recog-
nition of the C-terminal translocation signal in SidG. These
experiments suggest sequences that are N-terminal to the
SidG translocation signal confer the icmSW-dependent trans-
location phenotype observed for the full-length fusion
protein. To identify sequences necessary for the icmSW-
dependent phenotype, N-terminal sequences were deleted
and translocation efﬁciencies of the deletion derivatives were
compared between wild-type L. pneumophila and the DicmS,
DicmW double mutant. Efﬁcient translocation of Cya-
SidG(500–965) required the IcmSW complex, whereas an
icmSW-independent translocation phenotype was observed
for the Cya-SidG(600–965) protein (Figures 4B and S2). These
data deﬁne a central region in the SidG protein as being
important for the icmSW-dependent translocation phenotype,
and indicate that this internal region negatively impacts SidG
translocation in the absence of the IcmSW complex.
IcmS and IcmW Interactions with SidG Are Outside of the
Translocation Signal
IcmSW binding to SidG was analyzed by co-puriﬁcation of
recombinant proteins produced in E. coli [21]. N-terminal
hexa-histidine-tagged IcmW (H6IcmW) and IcmS were pro-
duced from a bi-cistronic message in conjunction with M45-
epitope-tagged SidG produced from a second vector in the
same E. coli cell [21]. H6IcmW and associated proteins were
captured from lysates on afﬁnity columns. These data show
that SidG co-puriﬁed with the H6IcmW/IcmS complex
isolated from E. coli cells producing the three proteins (Figure
5A). RalF did not co-elute with the H6IcmW/IcmS complex
when produced in the same E. coli cell, as shown previously
(Figure 5A) [21]. Additionally, SidG produced in the absence
of the IcmSW complex did not bind to the afﬁnity column
(Figure 5B). These data demonstrate that SidG contains
binding sites that mediate speciﬁc interactions with the
IcmSW complex.
Further analysis of SidG interactions with the IcmSW
complex revealed that H6IcmW/IcmS complex immobilized
on a column was unable to bind SidG protein contained in E.
coli lysates (Figure 5C), suggesting that interactions between
SidG and IcmSW occur in the cell before SidG folding has
been completed. When M45-SidG was co-expressed in E. coli
with either H6IcmS or H6IcmW, binding of SidG to these
individual components of the IcmSW complex was detected
(Figure 5D). The control protein RalF did not co-purify with
either H6IcmS or H6IcmW (Figure 5D). These data suggest
that IcmS and IcmW each have effector binding activity.
LvgA is a factor that has been shown to contribute to the
stability of IcmS and IcmW in L. pneumophila cells by
interacting directly with IcmS [39,40]. SidG did not co-purify
with H6LvgA when both proteins were produced in E. coli
(Figure 5D). Additionally, translocation of Cya-SidG by an
Figure 3. SidG Contains a C-Terminal Translocation Signal
(A) Schematic representation of the 965-aa SidG protein, which contains
an extensive coiled-coil region (grey) as well as two hydrophobic
segments (black). The identified translocation signal is depicted (T).
(B and C) CHO FccRII cells were infected with wild-type (black) or DdotA
(dark grey) strains expressing the indicated Cya-SidG hybrid proteins for
1 h. Total cAMP production induced by translocation of the hybrid was
determined as in Figure 1.
doi:10.1371/journal.ppat.0030188.g003
Figure 4. The C-Terminal Translocation Signal of SidG Supports icmSW-
Independent Translocation
(A) CHO FccRII cells were infected with wild-type (black), DdotA (dark
grey), or DicmS, DicmW (light grey) strains expressing indicated Cya-SidG
hybrid proteins for 1 h. Total cAMP production induced by translocation
of the hybrid was determined as in Figure 1.
(B) CHO FccRII cells were infected with wild-type or DicmS, DicmW strains
expressing the indicated Cya-SidG hybrid proteins for 1 h. Total cAMP
production induced by translocation of the hybrid was determined for
each strain. % values represent translocation efficiency as a measure of
(DicmS, DicmW) / wild-type for the indicated Cya-SidG hybrid proteins.þ
indicates that cAMP production induced by translocation of the hybrid in
DicmS, DicmW exceeded levels produced in wild-type.
doi:10.1371/journal.ppat.0030188.g004
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IcmSW Interactions with Dot/Icm EffectorslvgA mutant was not as severely attenuated as that observed
for Cya-SidG in the DicmS mutant (Figure S3). These data
suggest that LvgA is not interacting with effectors directly to
regulate translocation.
Deletion derivatives were analyzed to identify potential
binding regions for the IcmSW complex on SidG. N-terminal
deletion analysis revealed interactions between H6IcmW/
IcmS and SidG(500–965) (Figure 5E). The SidG(600–965) protein
did not interact with H6IcmW/IcmS, indicating that a binding
region for IcmSW is located in the SidG(500–600) region.
Interestingly, when C-terminal deletions were analyzed, an
interaction between IcmSW and SidG(1–500) was observed
(Figure 5E). This suggests the existence of a second IcmSW
binding region located in the SidG(1–500) region. Further
deletion analysis revealed that SidG(1–300) failed to bind
IcmSW. These data suggest that a second binding region for
IcmSW resides between residues 300 and 500. Collectively,
these data suggest that the SidG(300–600) region contains at
least two IcmSW binding sites (Figure 5F), the locations of
which are consistent with translocation data indicating that
regions outside of the C-terminal translocation signal
sequence are the targets for IcmSW function.
SidG Stability, Solubility, and Sub-Cellular Localization Is
Not Altered by IcmSW
The binding of IcmSW to effectors suggests that this
complex plays a role in maintaining full-length SidG in a
translocation-competent state. One possible mechanism of
IcmSW action would be to prevent deleterious interactions
from occurring that prevent SidG from being properly
engaged by the Dot/Icm system, which was investigated. In
Figure 2C, the absence of the IcmSW complex was shown not
have a dramatic effect on steady-state protein levels for the
different Cya-Sid hybrids, suggesting that IcmSW is not
important for preventing the degradation of effectors.
Additionally, we found that IcmSW was not important for
maintaining intracellular levels of M45-tagged SidG (Figure
6A), and the half-life of SidG was not affected in the L.
pneumophila DicmS, DicmW double mutant (Figure 6B). These
data indicate that the decrease in SidG translocation
observed for mutants deﬁcient in the IcmSW complex was
not due to reduced cellular levels of SidG.
Fractionation of bacterial cells revealed that there was no
difference in the sub-cellular localization or solubility of RalF
or SidG in wild-type L. pneumophila compared to the DicmS,
DicmW double mutant (Figure 6C and 6D). Some of the SidG
protein from bacterial lysates was located in a pellet fraction
and could be extracted from this fraction using TritonX-100.
Deletion of the C-terminal 180 aa of SidG (SidG(1–785)) did not
affect localization of the protein. When hydrophobic seg-
ments in SidG predicted to be membrane-spanning domains
were deleted, the resulting SidG(1–690) protein was found
exclusively in the soluble fraction, suggesting that the
hydrophobic segments are capable of mediating membrane
Figure 5. IcmSW Complex Binds to a Region of SidG That Is Distinct from
the C-Terminal Translocation Domain
(A) E. coli expressing H6IcmW/IcmS, and either M45-RalF or M45-SidG
were lysed (T), clarified, and loaded (L) onto affinity columns, washed (W),
and eluted (E). Fractions were resolved on SDS-PAGE, where H6IcmW/
IcmS were detected with Coomassie staining, and RalF or SidG was
detected by immunoblotting with M45-specific antisera. MW indicators
for the gel are shown on the left (kDa).
(B) E. coli expressing M45-SidG alone was subjected to affinity
purification as in (A). M45-SidG was detected as in (A).
(C) Lysate from E. coli expressing H6IcmW/IcmS was pre-charged onto
affinity column (1), washed, and subjected to lysate from E. coli
expressing M45-SidG (2) (L). Flow-through (FT) was collected and the
column was washed and eluted with buffer containing the indicated
concentration of imidazole. M45-SidG was detected as in (A).
(D) E. coli strains expressing H6IcmS, H6IcmW, or H6LvgA and M45-SidG or
M45-RalF were subjected to affinity purification as in (B). M45-SidG or
M45-RalF was detected as in (A).
(E) E. coli expressing H6IcmW/IcmS, and indicated M45-tagged SidG
truncations were lysed (T), clarified (S), and loaded (L) onto affinity
columns, and washed and eluted with buffer containing imidazole in the
indicated concentrations. Purified M45-SidG fragments were resolved on
SDS-PAGE and detected as in (A).
(F) Schematic representation of the genetic (arrows) and biochemical
(hatch) contribution of IcmSW on SidG translocation. At least one IcmSW
binding site resides between residues 500 and 600 of SidG [1], with
additional binding sites located between residues 300 and 500 [2]. The
IcmSW binding region is distinct from the C-terminal translocation
domain (T).
doi:10.1371/journal.ppat.0030188.g005
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IcmSW Interactions with Dot/Icm Effectorsassociation (Figure 6D). The SidG(691–965) protein, which
harbors the putative membrane-spanning regions, fractio-
nated with TritonX-100-soluble membrane proteins when
expressed in L. pneumophila, providing additional evidence
that these hydrophobic regions mediate membrane inter-
actions (Figure 6D). No differences for these SidG deletion
derivatives were observed when sub-cellular localization of
the proteins was compared in wild-type L. pneumopihla cells to
DicmS, DicmW double mutant cells. Although these data
suggest that SidG has the potential to associate with
membranes, the IcmSW complex did not affect this local-
ization.
To determine whether the absence of IcmSW results in
SidG aggregation, gel ﬁltration chromatography was used to
compare the mobility of SidG produced in wild-type L.
pneumophila to SidG produced in a DicmS, DicmW double
mutant (see Protocol S1). SidG was not detected in the void
volume when lysates from wild-type or DicmS, DicmW double
mutant L. pneumophila were fractionated using a Superdex-
200 column, suggesting that SidG protein aggregates were not
present in the lysates (Figure S4). Interestingly, the mobility
of SidG isolated from the DicmS, DicmW double mutant was
slightly different from the mobility of SidG isolated from
wild-type L. pneumophila. This could reﬂect a conformational
difference in the SidG protein or this shift could be the direct
result of IcmSW being associated with SidG. In addition to gel
ﬁltration, glycerol gradient centrifugation was used to
examine whether SidG aggregates were present in the DicmS,
DicmW double mutant (see Protocol S1). Consistent with the
gel ﬁltration results, glycerol gradients revealed no evidence
of SidG aggregation in the DicmS, DicmW double mutant
(Figure S4). Thus, we conclude that the reduction of SidG
translocation in the DicmS, DicmW double mutant is not the
result of rapid degradation of SidG, alterations in the
solubility of SidG, or differences in the sub-cellular local-
ization of SidG in the DicmS, DicmW double mutant. It is
possible, however, that IcmSW binding alters the conforma-
tion of SidG, and that this could be important for engage-
ment of SidG by the Dot/Icm system.
IcmSW Binding Alters the Accessibility of Proteases to
SidG
If the primary role of the IcmSW complex is to facilitate a
C-terminal signal sequence being displayed by an effector
protein, the percent decrease in translocation of an effector
observed using a DicmS, DicmW double mutant would
Figure 7. Overproduction of SidG Can Bypass the icmSW Requirement
(A) CHO FccRII cells were infected with wild-type (black), DdotA (dark
grey), or DicmS, DicmW (light grey) L. pneumophila strains expressing the
indicated Cya-SidG proteins for 1 h. Cultures that were grown in the
presence of 1 mM IPTG prior to and during infection are indicated (Cya-
SidG
þþ). Total cAMP production induced by translocation of the hybrid
was determined as in Figure 1.
(B) Immunoblots of whole-cell bacterial extracts expressing Cya-SidG
cultured in the absence or presence of 1 mM IPTG (Cya-SidG
þþ). Proteins
from wild-type (WT) or DicmS, DicmW (SW) were probed with
monoclonal antibody specific to the M45 epitope. Immunoblots for
chloramphenicol acetyltransferase (Cat) are included as a load control.
doi:10.1371/journal.ppat.0030188.g007
Figure 6. IcmSW Complex Does Not Influence the Stability, Solubility, or
Sub-Cellular Localization of SidG
(A) Immunoblots of whole-cell bacterial extracts expressing M45-SidG or
M45-RalF proteins from wild-type (WT) or DicmS, DicmW (SW) probed
with monoclonal antibody specific to the M45 epitope. Immunoblots for
chloramphenicol acetyltransferase (Cat) are included as a load control.
(B) Aliquots containing total protein from stationary phase wild-type or
DicmS, DicmW L. pneumophila strains were precipitated ( ). Cultures
were harvested, resuspended in media containing kanamycin, and
allowed to incubate at 37 8C for times indicated. Aliquots were mixed in
sample buffer, resolved on SDS-PAGE, and detected with immunoblot-
ting.
(C) Wild-type or DicmS, DicmW mutant L. pneumophila expressing M45-
RalF was cultured to stationary phase, harvested, lysed, and clarified (T).
Ultracentrifugation separated a soluble (S) fraction from insoluble
material. Inner membrane protein extraction with TritonX-100 (X) and
subsequent ultracentrifugation separated this population from insoluble
material (I). Protein contained in each fraction was detected with SDS-
PAGE and immunoblotting. Immunoblots for (Cat) are included as a
soluble protein control.
(D) Wild-type or DicmS, DicmW mutant L. pneumophila expressing M45-
SidG or indicated (*) SidG truncation proteins were cultured and
subjected to sub-cellular fractionation as in (C). Protein contained in each
fraction was detected with SDS-PAGE and immunoblotting. Immuno-
blots for (Cat) are included as a soluble protein control.
doi:10.1371/journal.ppat.0030188.g006
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IcmSW Interactions with Dot/Icm Effectorscorrelate with a drop in the ratio of effector in a conforma-
tional state where the C-terminal domain is accessible.
Accordingly, increasing the total amount of SidG in the cell,
which would increase the total number of SidG molecules in a
conformational state where the C-terminal domain is
accessible, should suppress the translocation defect in the
DicmS, DicmW double mutant. By contrast, if the primary role
of the IcmSW complex is to prevent effector proteins from
aggregating, overproduction of the effector should augment
the translocation defect. To determine whether overproduc-
tion of SidG had any effect on translocation by the Dot/Icm
system, Cya-SidG production was increased using a heterol-
ogous IPTG-inducible promoter upstream of the gene
encoding the reporter. After Cya-SidG production was
upregulated by IPTG induction, translocation levels were
measured and compared with previous translocation data. As
shown in Figure 7, IPTG induction of the gene encoding Cya-
SidG in the DicmS, DicmW double mutant resulted in a 10-fold
increase in translocation compared to the control in which
IPTG was not added. IPTG induction of the gene encoding
Cya-SidG in the wild-type strain resulted in only a modest
increase in translocation, indicating that the amount of SidG
in a translocation-competent state is near saturation in the
wild-type strain.
The hypothesis that IcmSW binding to effectors results in a
conformational change that enhances recognition of the C-
terminal translocation domain predicts that alterations in the
C-terminal region of an effector could also reduce the
requirement for IcmSW binding to an effector by enhancing
presentation of the translocation domain. To address this
possibility, an 8-aa FLAG epitope containing multiple
charged residues was positioned at the C-terminus of RalF
and SidG fusion proteins having M45-Cya at the N-terminus.
The FLAG-tagged RalF and SidG proteins were expressed in
either wild-type L. pneumophila or the DicmS, DicmW double
mutant to assay translocation. In wild-type L. pneumophila the
Cya-SidG
FLAG protein was translocated to levels similar to
those of the Cya-SidG protein, indicating that the C-terminal
FLAG epitope does not affect SidG translocation (Figure 8A).
In the DicmS, DicmW double mutant, translocation of the Cya-
SidG
FLAG protein was 100-fold higher than translocation of
the control Cya-SidG protein, indicating that inclusion of an
amino terminal FLAG tag greatly reduces the requirement
for icmSW. The observation that translocation of the Cya-
SidG
FLAG protein was still reduced in the DicmS, DicmW
double mutant compared to translocation by wild-type L.
pneumophila indicates that the FLAG tag does not fully
suppress the requirement for icmSW, which suggests that the
tag does not disrupt the conformation of the SidG protein to
the same extent as IcmSW binding. The Cya-RalF
FLAG hybrid
was not translocated to detectable levels, consistent with
previous results demonstrating that the RalF C-terminal
translocation domain is non-functional when masked by an
epitope tag (Figure 7B) [32]. Both RalF and SidG hybrids were
detected at similar levels from wild-type L. pneumophila and
the DicmS, DicmW double mutant using antiserum speciﬁc for
either the N-terminal M45 epitope or the C-terminal FLAG
epitope (Figure 8B), suggesting that protein stability was not
altered signiﬁcantly by addition of the C-terminal FLAG tag.
Expression of SidG
FLAG with the Cya domain removed
resulted in equivalent amounts of steady-state protein levels
detected in wild-type L. pneumophila and the DicmS, DicmW
double mutant when total protein was precipitated from
whole cells (Figure 8C). When bacteria were lysed in the
absence of protease inhibitors, however, the SidG
FLAG protein
produced by the DicmS, DicmW double mutant showed signs of
degradation by an endogenous protease (Figure 8D). This
result suggested that IcmSW binding to SidG
FLAG promotes a
conformational change in the substrate that affects protease
sensitivity following bacterial disruption. A polyclonal anti-
body speciﬁc for the C-terminal 90 aa of the SidG polypep-
tide was used to examine whether the binding of IcmSW to
SidG results in a conformational change that can be detected
by protease accessibility. This antibody detected endogenous
SidG produced by wild-type L. pneumophila and showed that
endogenous SidG levels were similar in the DicmS, DicmW
double mutant (Figure 9A), providing further evidence that
the IcmSW complex is not required for SidG stability.
To determine whether IcmSW binding alters protease
accessibility, RalF and SidG were produced in E. coli in either
the absence or presence of the H6IcmW/IcmS complex.
Cleavage products from whole cell lysates partially digested
with trypsin were detected by immunoblot analysis using
antibodies speciﬁc for RalF or SidG (Figure 9B). Cleavage
Figure 8. A C-Terminal FLAG Epitope Alters the Requirement for icmSW
in SidG Translocation
(A) CHO FccRII cells were infected with wild-type (black), DdotA (dark
grey), or DicmS, DicmW (light grey) strains expressing the indicated Cya
hybrid proteins. Total cAMP production induced by translocation of the
hybrid was determined as in (Figure 1). % values represent translocation
efficiency as a measure of (DicmS, DicmW) / wild-type.
(B) Immunoblots of whole-cell bacterial extracts expressing Cya-SidG
FLAG
or Cya-RalF
FLAG proteins from wild-type (WT) or DicmS, DicmW (D)
probed with monoclonal antibodies specific to the M45 or FLAG
epitopes. Immunoblots for chloramphenicol acetyltransferase (Cat) are
included as a load control.
(C) Immunoblots of whole-cell bacterial extracts expressing SidG
FLAG
from wild-type (WT) or DicmS, DicmW (SW) probed with monoclonal
antibody specific to the FLAG epitope.
(D) SidG
FLAG was expressed in wild-type or DicmS, DicmW L. pneumophila
strains to stationary phase. Cultures were harvested, lysed in the absence
of protease inhibitors, and clarified. Lysates were subjected to serial
dilutions that were mixed with sample buffer and analyzed by SDS-PAGE
and immunoblotting with monoclonal antisera specific for the FLAG
epitope.
doi:10.1371/journal.ppat.0030188.g008
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IcmSW Interactions with Dot/Icm Effectorsproducts observed for RalF were indistinguishable in the
presence and absence of the H6IcmW/IcmS complex. These
data indicate that IcmSW does not affect RalF conformation
and are consistent with data showing that IcmSW does not
bind to RalF. Differences in the appearance of a predominant
SidG cleavage product were observed when reactions
containing IcmSW were compared to reactions without
IcmSW, which is consistent with the hypothesis that IcmSW
binding alters the conformation of SidG (Figure 9B). Similar
assays were performed on SidG lysates where the trypsin was
diluted 1,000-fold. A difference in the appearance of a major
cleavage product was again observed when reactions con-
taining IcmSW were compared to reactions without IcmSW
(Figure 9C). Importantly, cleavage products in a size range
between 50 kDa and 60 kDa were detected in reactions
without the IcmSW complex, and were less prominent in
reactions containing the IcmSW complex. Because the SidG
antibody recognizes the C-terminal 90-aa region of the
protein, the locations of the cleavage sites must be located
between residues 400 and 500 of SidG. These data are
consistent with IcmSW interactions with SidG protecting
protease-sensitive sites in the region required for IcmSW
binding. To more carefully examine the emergence of these
cleavage products, a time course experiment was performed
with a constant protease concentration (Figure 9D). Again,
SidG cleavage products in the 50- to 60-kDa range preferen-
tially emerge in lysates that do not contain IcmSW.
Collectively, these results indicate that IcmSW alters the
conformation of SidG, and suggest that binding of IcmSW to
the central core of SidG protects protease sensitive sites.
Discussion
Over 50 different L. pneumophila Dot/Icm effectors have
been identiﬁed, and the total number of effectors is expected
to exceed 150 [12–26]. Secondary structure predictions
indicate that L. pneumophila effectors are diverse (Figures S1
and 6D). There are effectors with predicted membrane-
spanning helices, regions of coiled-coil domains, and homol-
ogies found primarily among eukaryotic proteins. How such a
large number of effectors with such diverse structural
properties can be efﬁciently recognized by a single secretion
system is a question of fundamental importance. Analysis of
the RalF protein has shown that substituting individual amino
acids at positions near the C-terminus can dramatically
reduce Dot/Icm-mediated translocation [32], which is con-
sistent with studies of other type IV secretion systems where
individual amino acid residues critical for type IV trans-
location have been identiﬁed near the C-terminus [29]. The
C-terminal 20-aa residues that comprise the translocation
signal for the RalF protein were disordered in the X-ray
crystal structure [35]. This has led to speculation that a
disordered C-terminal domain could be important for
effector protein engagement with the type IV secretion
machinery. In addition to a C-terminal translocation signal,
the IcmSW complex had been implicated as being important
for recognition of effector proteins by the Dot/Icm system
[21]. Here, we provide data that link the function of the
IcmSW complex with the hypothesis that a disordered C-
terminal secretion signal is important for effector protein
translocation.
Our data show that IcmSW can bind to effectors, that the
Figure 9. IcmSW Binding to SidG Promotes Conformational Changes in
the Effector Protein
(A) Schematic representation of the SidG polypeptide, with the IcmSW
binding domain shown (hatch) as well as the indicated C-terminal
domain (876–965) used for generation of polyclonal antisera. Full-length
SidG was detected at equivalent levels from wild-type (WT) or DicmS,
DicmW mutant L. pneumophila (SW) and was not detected in the sidG
deletion strain (DG).
(B) Recombinant RalF or SidG were co-expressed in the absence (vector)
or presence of the IcmSW complex (H6IcmW,IcmS), and subjected to lysis
and clarification. Aliquots of soluble whole-cell lysates were subjected to
the indicated concentrations of trypsin for 1 h. Samples were subjected
to SDS-PAGE and immunoblotting, where proteolytic fragments of RalF
(RalF ) or SidG (SidG ) were detected with specific antisera raised
against the indicated polypeptides. The black arrow indicates predom-
inant cleavage product.
(C) Lysates containing SidG were processed as in (B), except that trypsin
was diluted 1,000-fold. Proteolytic cleavage fragments (white arrows)
emerge in the absence of IcmSW in the molecular size range of 50–60
kDa as indicated by the asterisk.
(D) Proteolytic time course experiment performed at indicated concen-
tration (20 ng) on SidG-containing lysates. Immunoblots show differ-
ential cleavage products (arrows) in the 50–60 kDa molecular size range
(*).
doi:10.1371/journal.ppat.0030188.g009
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IcmSW Interactions with Dot/Icm Effectorsbinding region is located outside of the C-terminal trans-
location domain, and that Dot/Icm-mediated recognition of
the minimal C-terminal translocation domain does not
require the IcmSW complex (Figures 3, 4, and 5). These data
are inconsistent with the IcmSW complex functioning as an
adapter that facilitates recognition of a C-terminal trans-
location domain by binding to both the effector and the Dot/
Icm translocation apparatus. If the primary function of
IcmSW was to serve as an adapter, then removing the binding
site for IcmSW from an effector should result in a trans-
location defect in wild-type L. pneumophila that is comparable
with the translocation defect observed for the full-length
effector produced in the DicmS, DicmW double mutant. Our
data show the opposite. We found that removing regions
from the effector SidG that contained binding sites for the
IcmSW complex eliminated a requirement for the IcmS and
IcmW proteins for efﬁcient translocation (Figure 4). Taken
together, these data identify internal regions of an effector
protein that have a negative effect on recognition of the C-
terminal translocation signal and show that IcmSW binding
to these regions neutralizes this negative effect.
There are two likely explanations for why IcmSW binding
to an effector can neutralize intrinsic signals that interfere
with translocation. The ﬁrst is that IcmSW binding prevents
inappropriate interactions between the effector and other
proteins. Alternatively, IcmSW binding could prevent inter-
actions from occurring within the effector that masks
recognition by the Dot/Icm system. We were unable to show
that effectors are more prone to aggregation or degradation
in the absence of the IcmSW complex, which would be effects
that might result from inappropriate homo- or heterotypic
protein–protein interactions (Figures 6 and S4). The obser-
vation that overproduction of the effector protein SidG in an
DicmS, DicmW double mutant suppressed the translocation
defect also suggests that the IcmSW complex is not prevent-
ing inappropriate homo- or heterotypic protein–protein
interactions, as overexpression would most likely promote
these interactions and augment the translocation defect
(Figure 7).
Importantly, we were able to show that introduction of a
small epitope tag to the SidG C-terminus greatly affected the
icmSW dependency for translocation, and enhanced suscept-
ibility of SidG
FLAG to degradation following lysis of DicmS,
DicmW double mutant L. pneumophila, suggesting that IcmSW
binding alters the conformation of SidG (Figure 8). This
evidence was further supported by limited proteolysis experi-
ments that demonstrated conformational changes in SidG
induced by IcmSW binding. Thus, our data ﬁt better with a
model that predicts IcmSW binding to effectors facilitates the
display of the C-terminal translocation domain (Figure S5).
The model we propose also suggests that the IcmSW
complex binds to effectors before the proteins have folded
completely. Whether IcmSW binding to effectors is co-
translational or occurs after synthesis has been completed
can not be determined from our data; however, the
observation that puriﬁed IcmSW does not bind in vitro to
effectors expressed separately suggests that IcmSW binds
poorly to effectors in their native conformation. Importantly,
previous data has shown that IcmS binds very well to
members of the SidE family of effectors after transfer from
a SDS-PAGE gel to a nitrocellulose membrane, suggesting
that IcmS can bind to an immobilized effector in a denatured
state [25,36]. These data also imply that IcmS can bind to an
effector independent of IcmW. Consistent with these pre-
vious data, we show here that IcmS and IcmW can bind to the
effector protein SidG independent of each other and that
binding can be detected only when the proteins are
synthesized in the same bacterial cell (Figure 5). Although
effectors may have independent binding sites for IcmS and
IcmW, the observation that IcmW is highly unstable when it is
not associated with IcmS implies that these proteins function
as a complex [21].
It is signiﬁcant that IcmS and IcmW are relatively small
proteins predicted to have an acidic pI, which are properties
shared by chaperone proteins that function in the trans-
location of effector proteins by a type III secretion
mechanism [37]. The model we propose for the function of
the IcmSW complex has parallels to what is known about the
function of chaperones used for effectors translocated
through the type III secretion apparatus. Chaperones used
by the type III secretion system maintain effectors in a
partially unfolded state, which facilitates recognition of an N-
terminal secretion signal in type III effectors [42–46].
Recognition of the effector by the type III secretion system
stimulates disassembly of the chaperone–effector complex by
an ATPase that is essential for secretion system function
[44,47]. Our data suggest that IcmSW binding to effectors
facilitates display of a C-terminal translocation signal. There
are at least two proteins in the Dot/Icm system with predicted
nucleotide-binding sites that might engage effectors and
initiate translocation through the Dot/Icm system [39,48]. In
particular, the DotB protein is a critical component of the
Dot/Icm system that is thought to hydrolyze ATP to energize
transport of effectors through the apparatus [48]. It will be
interesting to test in the future whether DotB can recognize
C-terminal translocation signals directly and has an activity
that disassembles the IcmSW–effector protein complex.
The crystal structure of RalF and molecular analysis of this
protein have provided clues as to why not all Dot/Icm
effectors show the same level of dependency for IcmSW for
translocation [35]. RalF does not bind to IcmSW, the IcmSW
complex does not contribute to RalF translocation, and the
RalF protein has a disordered C-terminal translocation
signal. According to the RalF data, effectors having a C-
terminal translocation domain that is disordered in the
absence of IcmSW binding should be engaged by the Dot/Icm
system efﬁciently by mutants lacking the IcmSW complex.
This would explain why appending a minimal C-terminal
translocation sequence to Cya results in Dot/Icm-dependent
translocation by a process that is independent of IcmSW.
According to our model of IcmSW function, removal of
sequences that are N-terminal to the translocation signal of
an icmSW-dependent effector prevents complete folding of
the C-terminal domain containing this signal, mimicking
what occurs when IcmSW binds to the full-length effector.
Although the model we have put forward suggests that
IcmSW binding to effectors facilitates presentation of a C-
terminal translocation domain, it is possible that IcmSW
binding serves other functions that are more subtle and
difﬁcult to reveal using the assays available to measure
effector protein translocation and our limited knowledge of
the type IV secretion pathway. For instance, if type IV
effectors are translocated in a partially unfolded state, IcmSW
binding could potentially be important for translocation of
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once they have achieved their most thermodynamically stable
conformation. Additionally, with over 150 predicted effec-
tors, it remains unclear how translocation of effectors is
regulated and whether spatial and temporal regulation of
effector translocation is important for L. pneumophila modu-
lation of host cell functions [26,39,49,50]. Furthermore,
IcmSW could compete with inhibitory proteins that sequester
substrates under unfavorable conditions for translocation.
Whether IcmSW binding to effectors plays any role in
regulating the timing of effector translocation remains an
interesting possibility. As more information on the molecular
mechanisms important for type IV secretion become avail-
able, it should be possible to test how IcmSW might affect
recognition of effectors by other type IV secretion compo-
nents. In conclusion, these studies on IcmSW function have
provided new insight into how effector protein C-terminal
translocation domains are presented to the type IV machi-
nery and indicate that future studies on this interesting
chaperone complex should reveal new information on
biochemical activities important for effector protein trans-
location through the type IV apparatus.
Materials and Methods
Bacterial strains and plasmids. Bacterial strains, plasmids, and
primers used to generate constructs in this study are described in
Table S1. The sidG deletion strain was generated as described, using
the primers 69,70,71,103 [21]. L. pneumophila strains were cultivated on
charcoal yeast-extract agar (CYEA) or ACES yeast-extract broth
(AYE) (pH 6.9) supplemented with chloramphenicol (6.25 lg/ml), or
kanamycin (20 lg/ml) where appropriate. E. coli strains were
cultivated in Luria-Bertani (LB) broth supplemented with chloram-
phenicol (25 lg/ml), or ampicillin (100 lg/ml) where appropriate.
Cya translocation assay. Translocation assays were performed
as described [21]. Brieﬂy, monolayers containing 1310
5 CHO FccRII
cells were infected with 3 3 10
6 opsonized L. pneumophila (MOI ¼ 30)
expressing Cya hybrid proteins. After 1 h of incubation at 37 8C, 5%
CO2, monolayers were washed with PBS and lysed. Total cAMP was
extracted and quantiﬁed using cAMP Biotrak Enzymeimmunoassay
System (GE Healthcare). Where appropriate, cytochalasin D (10 lM)
(Sigma-Aldrich) was added to the tissue culture medium 30 min prior
to and throughout the infection.
Immunoblotting. Stationary phase L. pneumophila were harvested,
corrected for load (OD600), and precipitated in 10% trichloroacetic
acid. Precipitated protein was washed in acetone, resuspended in
sample buffer (62.5 mM Tris-HCl [pH 6.8], 20% SDS, 20% glycerol,
8% b-mercaptoethanol, 3 M urea), boiled, and loaded on 10% or 15%
SDS-PAGE. Gels were transferred to PVDF, and blocked and probed
with antibody speciﬁc for either the M45 epitope, DotA, RalF,
chloramphenicol acetyltransferase (Cat) (Sigma-Aldrich), or FLAG
(Sigma-Aldrich). Detection was carried out as described [21]. The
SidG polyclonal antibody was generated against puriﬁed recombi-
nant H6SidG876–965 by Cocalico Biologicals.
Phagocytosis assay. Monolayers of 1 3 10
5 CHO FccRII cells were
cultured in medium containing L. pneumophila–speciﬁc opsonizing
antibody for 1 h prior to infection. Where appropriate, cytochalasin
D was added to (10 lM) 30 min prior to infection. L. pneumophila
strains were added to the monolayer (MOI¼30), centrifuged 5 min at
1,000 rpm, heated to 37 8C in a water bath for 5 min, and subjected to
incubation at 37 8C, 5% CO2 for 1 h. Gentamycin (Invitrogen) was
added (10 lM) 15 min after infection where appropriate. Media was
aspirated from the monolayers and they were washed 3x with PBS.
Tissue culture cells were osmotically lysed with ice-cold H20 for 10
min. Lysates were resuspended and serially diluted, and aliquots were
plated on CYEA and incubated at 37 8C to determine colony-forming
units (CFU).
Co-puriﬁcation of the IcmSW complex with effectors. E. coli BL21-
DE3 (Novagen) was transformed with an expression vector (pEC66)
that harbors a di-cistronic message encoding H6icmW and icmS, as well
as a second expression vector that encodes an N-terminal M45
epitope–tagged hybrid to the L. pneumophila gene of interest (RalF or
SidG). Cultivation and co-puriﬁcation of complexes were performed
as described [21]. To examine the capture of SidG by H6IcmW/IcmS,
0.5-l cultures of E. coli BL21-DE3 expressing H6IcmW and IcmS were
cultivated either together or separately from an expression vector
producing M45-SidG. Cultures were harvested, resuspended in 22 ml
of lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM DTT, 1
mM PMSF), and subjected to lysis by French pressure cell (single pass
at 18,000 3 psi). Cultures were clariﬁed by centrifugation at 15,000g
for 15 min, and 20 ml of the supernatant was loaded onto a Ni-NTA
column (1 ml bed volume) (Qiagen) equilibrated with lysis buffer.
When produced separately, clariﬁed lysates from E. coli BL21-DE3
expressing M45-SidG were loaded on Ni-NTA columns that were pre-
charged with lysates expressing H6IcmW/IcmS and washed with 20 ml
lysis buffer. Full-length and truncation derivatives of M45-SidG that
were co-expressed with H6IcmW/IcmS were lysed, clariﬁed, and
loaded onto Ni-NTA columns under identical conditions. Columns
were washed with lysis buffer containing 10 mM imidazole, 5 mM
MgATP (20 ml), 25 mM imidazole (10 ml), 50 mM imidazole (10 ml),
and eluted with 500 mM imidazole (431 ml) in lysis buffer (fraction 2
shown). Each fraction is represented at equivalent volumes with the
exception of the eluate fractions, which are enriched 5x. Detection of
the IcmSW component was veriﬁed by mixing the eluate 1:1 with
sample buffer, resolving on 15% SDS-PAGE and Coomassie blue
staining. Detection of M45-tagged protein was visualized through
immunoblotting the fractions with monoclonal antisera speciﬁc to
the M45 epitope. Co-puriﬁcation of SidG or RalF with either H6IcmS
(pEC27), H6IcmW (pEC13), or H6LvgA (pEC329) was performed
similarly.
Pulse-chase analysis. L. pneumophila strains expressing N-terminal
M45 epitope–tagged effectors were cultured in AYE broth at 37 8Ct o
stationary phase, corrected for bacterial load by absorbance at 600
nm (10 ml of OD600 ¼ 4), and harvested by centrifugation. Samples
were aspirated and pellets were resuspended in 10 ml of pre-warmed
AYE broth (37 8C) supplemented with kanamycin (50 lg/ml). Cultures
were incubated in a 37 8C water bath, where aliquots of the
suspension were collected at incremental time points, precipitated
in 10% TCA, washed in acetone, resuspended in sample buffer, and
analyzed by SDS-PAGE and immunoblotting.
Sub-cellular fractionation. L. pneumophila strains expressing M45
epitope–tagged effectors (Ralf or SidG) were cultured in AYE broth at
37 8C to stationary phase, corrected for bacterial load by absorbance
at 600 nm (10 ml of OD600 ¼ 4), and harvested by centrifugation.
Bacterial pellets were resuspended in 0.5 ml ice-cold 200 mM Tris-
HCl (pH 8.0) and 0.5 ml ice-cold 50 mM Tris-HCl (pH 8.0), 1 M
sucrose). Then, 10 ll of 0.5 M EDTA (pH 8.0) and 10 ll of 10 mg/ml
lysozyme (Invitrogen) were added to the suspension, which was
diluted to a ﬁnal volume of 2 ml with ice-cold H2O. After 30 min on
ice, MgSO4 was added to a ﬁnal concentration of 20 mM.
Spheroplasts were harvested by centrifugation at 5,000g for 10 min,
and resuspended in 5 ml 50 mM Tris-HCl (pH 8.0). Samples were
subjected to lysis by sonication (3 3 30-sec bursts at 25%–35%
intensity) and were centrifuged at 5,000g for 10 min to produce a
clariﬁed lysate. The clariﬁed lysate was removed and subjected to
ultracentrifugation at 100,000g for 1 h (4 8C). The supernatant
fraction was separated from the pellet, and the pellet fraction was
resuspended in 1 ml Tris-HCl (pH 8.0). 10% TritonX-100 (in H2O)
was next added to the resuspended pellet fraction to achieve a ﬁnal
concentration of 1% (vol/vol) and incubated on ice for 30 min.
Suspensions were subjected to ultracentrifugation at 100,000g for 1 h
(4 8C). The supernatant fraction was separated from the pellet
fraction, which was resuspended in 1.1 ml Tris-HCl (pH 8.0). Each of
the four fractions were mixed 1:1 with sample buffer, and subjected
to 10% SDS-PAGE. Fractions were equivalently loaded on gels based
on the volume of buffer that the fraction received. Samples were
transferred to PDVF membrane and probed with monoclonal
antisera speciﬁc to the N-terminal M45 epitope tag.
Limited proteolysis. E. coli BL21-DE3 (Novagen) was transformed
with an expression vector alone (pET15b) or pEC66 that harbors a di-
cistronic message encoding H6icmW and icmS, as well as a second
expression vector that encodes an N-terminal M45 epitope–tagged
hybrid to the L. pneumophila gene of interest (RalF or SidG). Stationary
phase cultures were diluted 1:50 in 0.5 l and incubated on a shaker
(275 rpm) for 2 h at 37 8C. IPTG was added to a ﬁnal concentration of
1 mM and cultures were cultivated an additional 3 h at 37 8C. Cultures
were harvested, resuspended in 10 ml of lysis buffer (50 mM Tris-HCl
[pH 7.5], 150 mM NaCl, 1 mM DTT), and subjected to lysis by French
pressure cell (single pass at 18,000 3 psi). Cultures were clariﬁed by
centrifugation at 15,000g for 15 min and supernatants were adjusted
for total protein concentration by absorbance at 280 nm and dilution
with lysis buffer. Next, 100-ll aliquots were added to 40 ll lysis buffer
containing 0, 0.5, 5, 10, 20, or 40 lg trypsin (Sigma-Aldrich) on ice.
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whereas experiments performed at the ng scale were incubated at 37
8C for 1 h. After 1 h, PMSF was added to each sample to a ﬁnal
concentration of 1 mM. Time course experiments were performed
similarly, where each aliquot was subjected to 20 ng trypsin and
reactions were stopped with 1 mM PMSF. Each 140-ll reaction was
next mixed with 100 ll sample buffer, boiled, and subjected to SDS-
PAGE and immunoblotting with polyclonal antisera generated
against either RalF or SidG786–965.
Supporting Information
Figure S1. Dot/Icm Secretion Substrates Display Diverse Molecular
Character
(A) The Sid proteins utilized for this study are highlighted (bold-type).
Each substrate is drawn to scale as a measure of primary amino acid
sequence length, with regions containing coiled-coil homology
stretches shown in blue, and hydrophobic segments shown in red.
Several Sid proteins contain paralogous copies on the L. pneumophila
genome (grey). A 42-kDa RalF, which contains a Sec7 homology
domain (yellow), is included for size perspective.
(B) CHO FccRII cells were infected with wild-type (black) or DdotA
(grey) L. pneumophila strains expressing the indicated Cya hybrid
proteins. After 1 h of infection, tissue culture cells were lysed and
cAMP was extracted from the sample. Total cAMP production
induced by translocation of the hybrid was quantiﬁed using an
enzyme-immunoassay system, indicated as fmol. Results represent
average values 6 SD of experiments performed in triplicate.
Found at doi:10.1371/journal.ppat.0030188.sg001 (97 KB PDF).
Figure S2. Mapping the icmSW Requirement for SidG Translocation
(A) Schematic representation of indicated SidG truncation hybrids.
Each truncation was fused in frame to the C-terminal end of Cya.
Relative amino acid positions of SidG hybrids are indicated on the
right. icmS/W-independent translocation was observed for each
hybrid highlighted in green, while icmS/W-dependent translocation
was observed for each hybrid highlighted in red.
(B) CHO FccRII cells were infected with wild-type (black), DdotA (dark
grey), or DicmS, DicmW (light grey) L. pneumophila strains expressing
the indicated Cya-SidG hybrid proteins for 1 h. Total cAMP
production induced by translocation of the hybrid was determined
as in Figure S1.
Found at doi:10.1371/journal.ppat.0030188.sg002 (100 KB PDF).
Figure S3. Contribution of lvgA to the Translocation of RalF and SidG
(A) CHO FccRII cells were left uninfected (hatch) or infected with
wild-type (black), lvgA::TnNH3503 (dark grey), DicmS (light grey), or
DicmS, DicmW (white) L. pneumophila strains expressing the indicated
Cya hybrid proteins for 1 h. Total cAMP production induced by
translocation of the hybrid was determined as in Figure S1.
Found at doi:10.1371/journal.ppat.0030188.sg003 (40 KB PDF).
Figure S4. SidG Does Not Form Aggregates When Expressed in DicmS,
DicmW L. pneumophila
(A) M45-SidG was expressed in wild-type or DicmS, DicmW L.
pneumophila strains and cultured to stationary phase. Cultures were
harvested, lysed, clariﬁed, and subjected to gel ﬁltration chromatog-
raphy on a Superdex-200 column. Total protein was loaded at
equivalent levels (L). Peak elution of SidG expressed in the DicmS,
DicmW strain eluted earlier than of that expressed in wild-type
(dotted lines); however, no high molecular weight SidG aggregates
were detected.
(B) M45-SidG was expressed in wild-type or DicmS, DicmW L.
pneumophila strains and cultured to stationary phase. Cultures were
harvested, lysed, clariﬁed, and subjected to a 15%–45% glycerol
gradient. Fractions collected from the gradient were subjected to
SDS-PAGE and immunoblotting with antisera speciﬁc for the M45
epitope to detect SidG migration. DotA and RalF were detected with
speciﬁc monoclonal and polyclonal antisera, respectively.
Found at doi:10.1371/journal.ppat.0030188.sg004 (46 KB PDF).
Figure S5. Model Depicting the Contribution of IcmSW to the
Recognition of Effector Proteins by the Dot/Icm Transporter in L.
pneumophila
IcmS (red) and IcmW (blue) form a complex in the L. pneumophila
cytoplasm. Each factor harbors a binding activity on effectors, where
the complex might capture nascent chains emerging from ribosomes
prior to effector protein folding. IcmSW binding promotes a
conformational change in the effector that may facilitate presenta-
tion of the C-terminal translocation domain (green) to the Dot/Icm
machinery.
Found at doi:10.1371/journal.ppat.0030188.sg005 (88 KB PDF).
Protocol S1. Supplemental Materials and Methods
Found at doi:10.1371/journal.ppat.0030188.sd001 (28 KB DOC).
Table S1. Bacterial Strains, Plasmids, and Primers Employed in This
Study
Found at doi:10.1371/journal.ppat.0030188.st001 (157 KB DOC).
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